Skin microbiome modulator

This page covers all Skin microbiome modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 2 pipeline (1)

• DBI-002 Gel · DermBiont, Inc. · Dermatology
  DBI-002 Gel is a topical treatment that modulates the skin microbiome to improve symptoms of atopic dermatitis.

Patent intelligence

• skin microbiome modulator patent landscape — aggregated cliff calendar, attackable patents, originator estates